Retatrutide, from Soma Chems , is attracting considerable attention as a innovative therapy for metabolic control . This unique drug integrates the mechanism of a GLP-1 receptor agonist and a GIP receptor agonist , intended to effectively promote weight loss but also improve related metabolic factors. Early human studies have indicated encouraging